Infosys gains nearly 1% on signing deal with Prime Therapeutics

Subscribe to GoodReturns

Infosys gains nearly 1% on signing deal with Prime Therapeutics
Shares of Infosys rose nearly 1 per cent in early trade on Bombay Stock Exchange (BSE) after it said that it signed a three-year contract with Prime Therapeutics to set up a testing centre of excellence (COE) and consolidate the delivery of its application testing services

The shares of company rose as much as 0.92 per cent to trade at Rs 3258.35 a piece on the BSE.

In a similar fashion, shares of the company rose 0.93 per cent to Rs 3261 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 22,253.12, up 38.75 points or 0.17 per cent at 10:42 hours.

Dion Global Solutions Ltd.

Story first published: Friday, March 28, 2014, 13:07 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Find IFSC